Plain balloon angioplasty with or without bare-metal stenting <i>versus</i> drug-coated balloon angioplasty with or without bare-metal stenting <i>versus</i> primary drug-eluting stenting in patients requiring femoropopliteal, with or without infrapo
In BASIL-3, the probability of DCBA and of DES being cost-effective at £20 000 per QALY was 52% and 76% respectively. At a higher willingness-to-pay threshold (£30 000 per QALY) DES may be cost-effective and further research is required to explore the economic case.
Authors
- Deeks Jon
- Matthew Popplewell
- Gareth Bate (ORCID: https://orcid.org/0009-0005-3084-070X)
- Lisa Kelly
- Catherine A Moakes (ORCID: https://orcid.org/0000-0002-0473-0532)
- Jack A. Hall
- Mishal Javed
- Jesse Kigozi
- N Das
- R Davies
- A Saratzis
- L Wijesinghe
- S Habib
- J Sathianathan
- R White
- A Davies
- H Zayed
- N Arya
- R Das
- J Metcalfe
- A Chaudhuri
- N Goyal
- N Thayur
- A Rogers
- S Dindyal
- S Goode
- the BASIL-3 Investigators
- J Patel
- G Weir
- I Chetter
- N Arestis
- J Asquith
- S Butterfield
- G Stansby
- P Mezes
- R Eifell
- F Ahmad
- T Rashid
- S Hobbs
- G Antoniou
- M Caruna
- P Chong
- P Davey
- Andrew W Bradbury
- A Ganeshan
Institutions
- Birmingham City University (GB)
- University Hospitals Birmingham NHS Foundation Trust (GB)
- University Hospital of Wales (GB)
- University of Alabama at Birmingham (US)
- Guest Hospital (GB)
- University of Birmingham (GB)
Publication Details
- Journal
- British journal of surgery
- Published
- 2025-11-28
- DOI
- https://doi.org/10.1093/bjs/znaf274
- Primary Topic
- Peripheral Artery Disease Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00